Intellia Therapeutics NTLA Operating margin

Operating margin at other companies

Ionis PharmaceuticalsIONS

-68%-234pp

ALN

Alnylam PharmaceuticalsALNY

20.8%+16.5pp

CRISPR TherapeuticsCRSP

-15,754.2%-17,253pp

Beam TherapeuticsBEAM

-226.6%-90.5pp

Prime MedicinePRME

-4,498.1%-1,134pp

Iovance Biotherapeutics, Inc.IOVA

-92.7%-29.0pp

FAQ

What is Intellia Therapeutics's operating margin?

Intellia Therapeutics (NTLA) reported operating margin of -711.7% in Q2 2026.

How has Intellia Therapeutics's operating margin changed year-over-year?

Intellia Therapeutics's operating margin increased by 26.5% year-over-year, from -968.7% to -711.7%.

What is the long-term trend for Intellia Therapeutics's operating margin?

Over 5 years (2020 to 2025), Intellia Therapeutics's operating margin has grown at a 22.6% compound annual growth rate (CAGR), from -235.5% to -651.7%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.